Chemoenzymatic Modification of Daptomycin: Aromatic Group Installation on Trp1
ChemBioChem · 2024
DOI: 10.1002/cbic.202400503 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2024. Verfasst von Dustin A Dimas und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry and Biochemistry, University of Oklahoma, Stephenson Life Sciences Research Center, 101 Stephenson Parkway, Norman, Oklahoma,…. Hauptthemen laut MEDLINE: Daptomycin, Anti-Bacterial Agents, Tryptophan, Microbial Sensitivity Tests. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCRR NIH HHS, NSF, USDA.
Abstract (Originalsprache)
Daptomycin is a cyclic lipodepsipeptide antibiotic used to treat infections caused by Gram‐positive pathogens, including multi‐drug resistant strains such as methicillin‐resistant Staphylococcus aureus (MRSA) and vancomycin‐resistant enterococci (VRE). The emergence of daptomycin‐resistant bacterial strains has renewed interest in generating daptomycin analogs. Previous studies have shown that replacing the tryptophan of daptomycin with aromatic groups can generate analogs with enhanced potency. Additionally, we have demonstrated that aromatic prenyltransferases can attach diverse groups to the tryptophan of daptomycin. Here, we report the use of the prenyltransferase CdpNPT to derivatize the tryptophan of daptomycin with a library of benzylic and heterocyclic pyrophosphates. An analytical‐scale study revealed that CdpNPT can transfer various aromatic groups onto daptomycin. Subsequent scaled‐up and purified reactions indicated that the enzyme can attach aromatic groups to N 1, C 2, C 5 and C 6 positions of Trp1 of daptomycin. In vitro antibacterial activity assays using six of these purified compounds identified aromatic substituted daptomycin analogs show potency against both daptomycin‐susceptible and resistant strains of Gram‐positive bacteria. These findings suggest that installing aromatic groups on the Trp1 of daptomycin can lead to the generation of potent daptomycin analogs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry and Biochemistry, University of Oklahoma, Stephenson Life Sciences Research Center, 101 Stephenson Parkway, Norman, Oklahoma, 73019, United States.
- National Magnetic Resonance Facility at Madison, University of Wisconsin-Madison, 411 Babcock Drive, Madison, Wisconsin, 45005, United States.
ORCID-Profile: Shanteri Singh
Förderung
- NCRR NIH HHS
- NSF
- USDA
- NIH HHS
- NIGMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Dimas, D. A., Kumar, V., Mandal, P. S., Masterson, J. M., Tonelli, M., & Singh, S. (2024). Chemoenzymatic Modification of Daptomycin: Aromatic Group Installation on Trp1. ChemBioChem. https://doi.org/10.1002/cbic.202400503
Vancouver
Dimas DA, Kumar V, Mandal PS, Masterson JM, Tonelli M, Singh S. Chemoenzymatic Modification of Daptomycin: Aromatic Group Installation on Trp1. ChemBioChem. 2024. doi:10.1002/cbic.202400503
BibTeX
@article{Dimas2024,
author = {Dimas, Dustin A and Kumar, Vikas and Mandal, Prashant S and Masterson, Johanna M and Tonelli, Marco and Singh, Shanteri},
title = {Chemoenzymatic Modification of Daptomycin: Aromatic Group Installation on Trp1},
journal = {ChemBioChem},
year = {2024},
doi = {10.1002/cbic.202400503}
}
EUVIMED